These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28390290)

  • 1. Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
    Gleissner CA; Erbel C; Linden F; Domschke G; Akhavanpoor M; Helmes CM; Doesch AO; Kleber ME; Katus HA; Maerz W
    Atherosclerosis; 2017 May; 260():121-129. PubMed ID: 28390290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology.
    Gleissner CA; Erbel C; Linden F; Domschke G; Akhavanpoor M; Doesch AO; Buss SJ; Giannitsis E; Katus HA; Korosoglou G
    Atherosclerosis; 2016 Aug; 251():94-100. PubMed ID: 27295060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.
    Maiolino G; Rossitto G; Pedon L; Cesari M; Frigo AC; Azzolini M; Plebani M; Rossi GP
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):725-32. PubMed ID: 25614283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study.
    Lisowska A; Knapp M; Tycińska A; Motybel E; Kamiński K; Święcki P; Musiał WJ; Dymicka-Piekarska V
    Atherosclerosis; 2016 Mar; 246():309-17. PubMed ID: 26828748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease--results from the Ludwigshafen Risk and Cardiovascular Health Study (LURIC).
    Lepper PM; Kleber ME; Grammer TB; Hoffmann K; Dietz S; Winkelmann BR; Boehm BO; März W
    Atherosclerosis; 2011 Nov; 219(1):291-7. PubMed ID: 21722903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Galectin-3-Binding Protein and Metabolic Syndrome in a Chinese Adult Population.
    Zhen S; Cai R; Yang X; Ma Y; Wen D
    Front Endocrinol (Lausanne); 2021; 12():726154. PubMed ID: 34858323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.
    Li M; Pan W; Tian D; Chen D; Zhang X; Zhang Y; Chen S; Zhou D; Ge J
    Curr Vasc Pharmacol; 2024; 22(1):67-77. PubMed ID: 38038005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.
    Olivieri O; Martinelli N; Girelli D; Pizzolo F; Friso S; Beltrame F; Lotto V; Annarumma L; Corrocher R
    J Thromb Haemost; 2010 Mar; 8(3):463-71. PubMed ID: 20002542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Plasma Fetuin-A Levels Are Associated With a Higher Mortality Risk in Patients With Coronary Artery Disease.
    Chen X; Zhang Y; Chen Q; Li Q; Li Y; Ling W
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2213-2219. PubMed ID: 28912366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homoarginine, cardiovascular risk, and mortality.
    März W; Meinitzer A; Drechsler C; Pilz S; Krane V; Kleber ME; Fischer J; Winkelmann BR; Böhm BO; Ritz E; Wanner C
    Circulation; 2010 Sep; 122(10):967-75. PubMed ID: 20733103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Complement C1q to Predict 10-Year Mortality in Men With Diabetes Mellitus Referred for Coronary Angiography.
    Cavusoglu E; Kassotis JT; Anwar A; Marmur JD; Hussain SW; Yanamadala S; Hegde S; Parpas A; Eng C; Zhang M
    Am J Cardiol; 2018 Jul; 122(1):33-38. PubMed ID: 29703440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
    Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
    Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality risk of triglyceride levels in patients with coronary artery disease.
    Kasai T; Miyauchi K; Yanagisawa N; Kajimoto K; Kubota N; Ogita M; Tsuboi S; Amano A; Daida H
    Heart; 2013 Jan; 99(1):22-9. PubMed ID: 23014481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.
    Pilz S; Tomaschitz A; Drechsler C; Ritz E; Boehm BO; Grammer TB; März W
    Eur Heart J; 2010 Jul; 31(13):1591-8. PubMed ID: 20439261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery calcification outperforms thoracic aortic calcification for the prediction of myocardial infarction and all-cause mortality: the Heinz Nixdorf Recall Study.
    Kälsch H; Lehmann N; Berg MH; Mahabadi AA; Mergen P; Möhlenkamp S; Bauer M; Kara K; Dragano N; Hoffmann B; Moebus S; Schmermund A; Stang A; Jöckel KH; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1163-70. PubMed ID: 23467675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.
    Ostrom MP; Gopal A; Ahmadi N; Nasir K; Yang E; Kakadiaris I; Flores F; Mao SS; Budoff MJ
    J Am Coll Cardiol; 2008 Oct; 52(16):1335-43. PubMed ID: 18929245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
    Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.